How does one assess early rheumatoid arthritis in daily clinical practice?

This publication has 40 references indexed in Scilit:

• Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
  New England Journal of Medicine, 1997
• Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis
  Arthritis & Rheumatism, 1995
• Long-Term Usage and Side-Effect Profile of Sulphasalazine in Rheumatoid Arthritis
  Rheumatology, 1995
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
  The Lancet, 1994
• Clinical assessment and clinical trials in rheumatoid arthritis
  Current Opinion in Rheumatology, 1994
• FACTORS PREDICTING DEATH, SURVIVAL AND FUNCTIONAL OUTCOME IN A PROSPECTIVE STUDY OF EARLY RHEUMATOID DISEASE OVER FIFTEEN YEARS
  Rheumatology, 1993
• The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
  Arthritis & Rheumatism, 1993
• PROVISIONAL GUIDELINES FOR MEASURING DISEASE ACTIVITY IN CLINICAL TRIALS ON RHEUMATOID ARTHRITIS
  Rheumatology, 1992
• PROGNOSTIC FACTORS FOR RADIOGRAPHIC DAMAGE AND PHYSICAL DISABILITY IN EARLY RHEUMATOID ARTHRITIS. A PROSPECTIVE FOLLOW-UP STUDY OF 147 PATIENTS
  Rheumatology, 1992
• The development of disability in rheumatoid arthritis
  Arthritis & Rheumatism, 1986